A New Subcutaneous Immunoglobulin 20% Formulation (SCIG...

A New Subcutaneous Immunoglobulin 20% Formulation (SCIG 20%) with Individualized Infusion Parameters Resulted in a Positive Safety and Tolerability Profile in Patients with PIDD in Europe and North America

Suez, Daniel, Krivan, Gregely, Jolles, Stephen R., Hussain, Iftikhar, Stein, Mark R., Gupta, Sudhir, Paris, Kenneth, van Hagen, Martin, Brodszki, Nicholas, McCoy, Barbara, Yel, Leman
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
139
Language:
english
Journal:
Journal of Allergy and Clinical Immunology
DOI:
10.1016/j.jaci.2016.12.700
Date:
February, 2017
File:
PDF, 127 KB
english, 2017
Conversion to is in progress
Conversion to is failed